Back to Royce & Associates LP Royce & Associates LP

HBIO

26 quarters

Position history for Royce & Associates LPRoyce & Associates LP's holdings in Harvard Bioscience, Inc.

No. Royce & Associates exited its HBIO (Harvard Bioscience) position in Q2 2025. Its Q1 2025 13F listed 1,777,894 shares worth $1M. Royce & Associates already held HBIO in its Q1 2019 13F, the earliest on record, and held it in 25 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$7.5M

Total Shares Change

-1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$4.40
0
2025-Q1
Decreased
1.8M
-9.5%
$1M0.0%$5.70
0
2024-Q4
Increased
2M
+35.4%
$4.1M0.0%$21.10
35
2024-Q3
Increased
1.5M
+0.7%
$3.9M0.0%$26.90
27
2024-Q2
Increased
1.4M
+6.9%
$4.1M0.0%$28.50
29
2024-Q1
Decreased
1.3M
-7.0%
$5.7M0.1%$42.40
0
2023-Q4
Increased
1.5M
+2.9%
$7.8M0.1%$53.50
28
2023-Q3
Increased
1.4M
+0.7%
$6.1M0.1%$43.00
27
2023-Q2
Decreased
1.4M
-2.7%
$7.7M0.1%$54.90
0
2023-Q1
Increased
1.4M
+1.0%
$6M0.1%$42.00
27
2022-Q4
Decreased
1.4M
-4.9%
$3.9M0.0%$27.70
0
2022-Q3
Decreased
1.5M
-7.5%
$3.8M0.0%$25.60
0
2022-Q2
Decreased
1.6M
-3.9%
$5.8M0.1%$36.00
0
2022-Q1
Decreased
1.7M
-7.0%
$10.5M0.1%$62.10
0
2021-Q4
Decreased
1.8M
-0.3%
$12.8M0.1%$70.50
0
2021-Q3
Decreased
1.8M
-9.7%
$12.7M0.1%$69.80
0
2021-Q2
Increased
2M
+5.0%
$16.8M0.1%$83.30
35
2021-Q1
Increased
1.9M
+15.2%
$10.5M0.1%$54.60
32
2020-Q4
Increased
1.7M
+4.5%
$7.1M0.1%$42.90
29
2020-Q3
Decreased
1.6M
-15.0%
$4.8M0.1%$30.10
0
2020-Q2
Increased
1.9M
+11.5%
$5.8M0.1%$31.00
30
2020-Q1
Increased
1.7M
+1.8%
$3.7M0.1%$22.10
27
2019-Q4
Decreased
1.7M
-11.6%
$5M0.0%$30.50
0
2019-Q3
Increased
1.9M
+2.0%
$5.7M0.1%$30.80
28
2019-Q2
Increased
1.8M
+5.8%
$3.7M0.0%$20.00
28
2019-Q1
First report
1.7M
-
$7.5M0.1%$43.10
0

Other major holders of HBIO: Dimensional Fund Advisors LP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used